Stock Report

All about this stock under one free report Last Updated: 09-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Genomic Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 539206

₹30.20

up-down-arrow ₹0.32 (1.07%)

As on 08-Sep-2026IST

Market cap

info icon

₹9 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

439.3

P/B Ratio

info icon

2.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -57.78 -72.27 -50.18 1.76
EBIT 366.67 -44.00 -90.43 -68.14 16.23
Net Profit 300.00 -44.00 -91.46 -72.31 15.32
EPS 300.00 -44.01 -91.47 -53.98 15.32
Book Value -- -- 10.05 10.63 -5.03
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 30.85-143.6614.3551.808.66
Net Margin info 24.84-39.299.7241.979.11
Return on equity info 10.083.650.539.570.43
Return on Capital info 10.895.69--11.870.45
Return on Assets info 8.113.390.498.200.35
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
11.87
0.45
20.35
0.93
Peer Median
--
0.21
-0.29
0.84
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

0.53

Lower than Peers by 3.02

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
0.53
9.57
0.43
20.24
-0.25
Peer Median
3.56
-1.34
-0.26
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.49

Lower than Peers by 0.49

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
0.49
8.20
0.35
15.78
-0.16
Peer Median
0.98
-1.66
-3.42
0.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

14.35

Higher than Peers by 6.67

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
14.35
51.80
8.66
32.09
-654.36
Peer Median
7.69
37.55
10.05
6.96
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.72

Higher than Peers by 5.20

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
9.72
41.97
9.11
23.44
-6.04
Peer Median
4.52
-4.04
-7.43
-2.61
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
0.00
42.50
9.86
24.10
106.31
Peer Median
--
0.00
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-72.27

Lower than Peers by 76.29

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
-72.27
411.25
-93.94
3,758.23
-66.09
Peer Median
4.01
216.49
-2.29
7.94
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-90.43

Lower than Peers by 88.09

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
-90.43
2,957.90
-98.36
289.18
-41.80
Peer Median
-2.34
551.22
2.35
-65.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-91.46

Lower than Peers by 90.91

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
-91.46
2,245.51
-97.66
7,040.47
98.33
Peer Median
-0.55
295.65
-49.94
43.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-91.47

--

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
-91.47
2,245.67
-97.66
7,035.62
98.33
Peer Median
--
302.24
50.00
-71.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
10.05
0.43
22.52
-35.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
--
--
--
--
Peer Median
0.14
0.17
0.31
0.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

8.40

Higher than Peers by 6.98

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
8.40
5.73
3.68
2.89
5.31
Peer Median
1.42
1.00
1.17
1.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

7.52

Higher than Peers by 6.38

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
7.52
5.11
3.68
2.89
5.31
Peer Median
1.15
1.35
1.05
1.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
2,845.31
24.40
225.30
0.96
Peer Median
1.77
0.40
0.13
0.94
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

1,073.15

Higher than Peers by 1,046.28

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
1,073.15
262.40
1,532.71
81.45
--
Peer Median
26.87
146.71
25.11
24.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.05

Lower than Peers by 0.25

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
0.05
0.19
0.04
0.66
0.01
Peer Median
0.30
0.30
0.38
0.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
1,026.01
5,248.74
297.29
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
122.93
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
554.30
--
70.37
3,716.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
594.64
--
226.92
-3,716.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

439.27

No difference

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
439.27
50.26
698.34
--
--
Peer Median
439.27
46.29
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.34

No difference

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
2.34
4.59
2.99
--
--
Peer Median
2.34
3.88
0.74
1.53
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

262.82

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
262.82
40.19
627.44
3.26
-10.40
Peer Median
--
1.64
13.74
-0.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9

Lower than Peers by 218

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Genomic Biotech
9
18
11
--
--
Peer Median
227
131
213
263
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...